Case Stories

The importance of molecular testing to improve cancer patient outcomes - Dr. Allan Njau

101 views
February 17, 2020
Dr. Allan Njau, Anatomical Pathologist at the Aga Khan University Hospital, Kenya, discusses the importance of molecular testing to improve cancer patient outcomes.

Cancer incidence rates in Kenya are high and accompanied by elevated morbidity and mortality. Dr. Allan Njao discusses how molecular NGS testing paired with a comprehensive bioinformatics analysis and reporting pipeline, can help improve cancer patient outcomes.

Interested in learning more?

Click here

Related videos

Case Stories

The importance of a good bioinformatics pipeline for determining TMB score

111 views February 17, 2020

Tumor mutational burden is an important biomarker for immuno-oncology. Dr...

Case Stories

Dr. Sehime Temel of the Department of Medical Genetics at Uludag University discusses QDI

96 views February 17, 2020

Trying to find the appropriate genetic variant without bioinformatics is as...

Case Stories

Dr. Kambiz Karimi about the comprehensiveness of QIAGEN clinical insights

95 views February 17, 2020

Dr. Kambiz Karimi, Curation Manager at Counsyl, presented data as ASHG which...

Case Stories

#AACR19 Interview with Deep Pandya

80 views February 17, 2020

Deep Pandya, Bioinformatician at the Western Connecticut Health Network,...